March 27 (Reuters) – Medtronic said on Friday the U.S. Food and Drug Administration has cleared its surgical system for use in cranial and ear, nose and throat procedures, expanding the platform beyond the spine indication it received earlier this year.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shreya Biswas)
Comments